Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Antroquinonol |
| Synonyms | |
| Therapy Description |
Hocena (antroquinonol) is derived from the fungus, Antrodia camphorata, and has been reported to have antitumor effects against various cancer cells through inhibition of mTOR (PMID: 21185843). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Antroquinonol | Hocena | mTOR Inhibitor 51 | Hocena (antroquinonol) is derived from the fungus, Antrodia camphorata, and has been reported to have antitumor effects against various cancer cells through inhibition of mTOR (PMID: 21185843). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03310632 | Phase Ib/II | Antroquinonol | Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer | Active, not recruiting | USA | 2 |
| NCT02047344 | Phase II | Antroquinonol | Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC | Completed | USA | 1 |